Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Concentrix Corp Director's Dealing 2023

Oct 6, 2023

31393_dirs_2023-10-05_e82cf880-ed55-466d-8bf2-a31e0123c713.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: Concentrix Corp (CNXC)
CIK: 0001803599
Period of Report: 2023-09-25

Reporting Person: Duha Olivier (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-09-25 Contingent Right to Common Stock $ A 59421 Acquired Common Stock (59421) Direct
2023-09-25 Contingent Right to Common Stock $ A 16252 Acquired Common Stock (16252) Indirect
2023-09-25 Contingent Right to Common Stock $ A 1818 Acquired Common Stock (1818) Indirect

Footnotes

F1: On September 25, 2023, the Issuer completed its acquisition of the issued and outstanding capital stock of Marnix Lux SA, a public limited company (societe anonyme) organized under the Laws of the Grand Duchy of Luxembourg ("Marnix Lux"), the parent company of Webhelp, pursuant to the Share Purchase and Contribution Agreement dated June 12, 2023, as amended by the First Amendment to the Share Purchase and Contribution Agreement, dated July 14, 2023 by and among the Issuer, OSYRIS S.a.r.l., Marnix Lux and the holders of Marnix Lux (the "Transaction", and such agreement, as amended, the "Agreement").

F2: Pursuant to, and subject to the terms and conditions in, the Agreement, the Reporting Person has the contingent right to receive up to 59,421 shares of common stock of the Issuer if the share price of the Issuer's common stock reaches $170.00 per share within seven years from September 25, 2023 (based on daily volume weighted average prices measured over a specific period), or if within three years from September 25, 2023 the Issuer has a change of control with per share consideration of at least $150.00.

F3: Pursuant to, and subject to the terms and conditions in, the Agreement, the Reporting Person has the contingent right to receive up to 16,252 shares of common stock of the Issuer if the share price of the Issuer's common stock reaches $170.00 per share within seven years from September 25, 2023 (based on daily volume weighted average prices measured over a specific period), or if within three years from September 25, 2023 the Issuer has a change of control with per share consideration of at least $150.00.

F4: Pursuant to, and subject to the terms and conditions in, the Agreement, the Reporting Person has the contingent right to receive up to 1,818 shares of common stock of the Issuer if the share price of the Issuer's common stock reaches $170.00 per share within seven years from September 25, 2023 (based on daily volume weighted average prices measured over a specific period), or if within three years from September 25, 2023 the Issuer has a change of control with per share consideration of at least $150.00.